Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics of Streptococcus agalactiae causing urinary tract infections: Emergence of new sequence types ST74 and ST38 in Iran. | Iran J Basic Med Sci | 2023 | 37970443 | PubTator, text mining | PubMed |
| Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer. | Explor Target Antitumor Ther | 2023 | 37970212 | PubTator, text mining | PubMed |
| A Novel Molecular Classification Method for Glioblastoma Based on Tumor Cell Differentiation Trajectories. | Stem Cells Int | 2023 | 37964983 | PubTator, text mining | PubMed |
| Interaction of βL- and γ-Crystallin with Phospholipid Membrane Using Atomic Force Microscopy. | Int J Mol Sci | 2023 | 37958704 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy. | BMC Cancer | 2023 | 37957639 | PubTator, text mining | PubMed |
| Development and function of chicken XCR1+ conventional dendritic cells. | Front Immunol | 2023 | 37954617 | PubTator, text mining | PubMed |
| Review of T cell proliferation regulatory factors in treatment and prognostic prediction for solid tumors. | Heliyon | 2023 | 37954355 | PubTator, text mining | PubMed |
| Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers. | Breast Cancer (Dove Med Press) | 2023 | 37954171 | PubTator, text mining | PubMed |
| The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer. | Sci Rep | 2023 | 37945594 | PubTator, text mining | PubMed |
| Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States. | BMC Cancer | 2023 | 37932662 | PubTator, text mining | PubMed |
Prevalence and distribution of subtypes of Blastocystis in Asiatic brush-tailed porcupines (Atherurus macrourus), bamboo rats (Rhizomys pruinosus), and masked palm civets (Paguma larvata) farmed in Hainan, China. | Parasite | 2023 | 37921619 | PubTator, text mining | PubMed |
| Gua-Sha therapy on breast engorgement among Indian postnatal mothers. | Bioinformation | 2023 | 37908615 | PubTator, text mining | PubMed |
| Design and Characterization of Model Systems that Promote and Disrupt Transparency of Vertebrate Crystallins In Vitro. | Adv Sci (Weinh) | 2023 | 37897315 | PubTator, text mining | PubMed |
| Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer. | Pharmaceuticals (Basel) | 2023 | 37895937 | PubTator, text mining | PubMed |
| Recent Progress on Genetically Modified Animal Models for Membrane Skeletal Proteins: The 4.1 and MPP Families. | Genes (Basel) | 2023 | 37895291 | PubTator, text mining | PubMed |
| Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas. | Int J Mol Sci | 2023 | 37894937 | PubTator, text mining | PubMed |
| The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening. | Curr Issues Mol Biol | 2023 | 37886977 | PubTator, text mining | PubMed |
| The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment. | Curr Issues Mol Biol | 2023 | 37886952 | PubTator, text mining | PubMed |
| The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells. | Cancer Cell Int | 2023 | 37880659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=11